These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35250809)

  • 1. Serum Creatine, Not Neurofilament Light, Is Elevated in CHCHD10-Linked Spinal Muscular Atrophy.
    Järvilehto J; Harjuhaahto S; Palu E; Auranen M; Kvist J; Zetterberg H; Koskivuori J; Lehtonen M; Saukkonen AM; Jokela M; Ylikallio E; Tyynismaa H
    Front Neurol; 2022; 13():793937. PubMed ID: 35250809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the Jokela type of spinal muscular atrophy-related G66V mutation on the structural ensemble characteristics of CHCHD10.
    Alici H; Uversky VN; Kang DE; Woo JA; Coskuner-Weber O
    Proteins; 2023 Jun; 91(6):739-749. PubMed ID: 36625206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of CHCHD10-related diseases.
    Genin EC; Bannwarth S; Lespinasse F; Ortega-Vila B; Fragaki K; Itoh K; Villa E; Lacas-Gervais S; Jokela M; Auranen M; Ylikallio E; Mauri-Crouzet A; Tyynismaa H; Vihola A; Augé G; Cochaud C; Sesaki H; Ricci JE; Udd B; Vives-Bauza C; Paquis-Flucklinger V
    Neurobiol Dis; 2018 Nov; 119():159-171. PubMed ID: 30092269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle and not neuronal biomarkers correlate with severity in spinal and bulbar muscular atrophy.
    Lombardi V; Querin G; Ziff OJ; Zampedri L; Martinelli I; Heller C; Foiani M; Bertolin C; Lu CH; Malik B; Allen K; Rinaldi C; Zetterberg H; Heslegrave A; Greensmith L; Hanna M; Soraru G; Malaspina A; Fratta P
    Neurology; 2019 Mar; 92(11):e1205-e1211. PubMed ID: 30787165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHCHD10 variant p.(Gly66Val) causes axonal Charcot-Marie-Tooth disease.
    Auranen M; Ylikallio E; Shcherbii M; Paetau A; Kiuru-Enari S; Toppila JP; Tyynismaa H
    Neurol Genet; 2015 Jun; 1(1):e1. PubMed ID: 27066538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum biomarkers in primary mitochondrial disorders.
    Varhaug KN; Hikmat O; Nakkestad HL; Vedeler CA; Bindoff LA
    Brain Commun; 2021; 3(1):fcaa222. PubMed ID: 33501425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late onset spinal motor neuronopathy is caused by mutation in CHCHD10.
    Penttilä S; Jokela M; Bouquin H; Saukkonen AM; Toivanen J; Udd B
    Ann Neurol; 2015 Jan; 77(1):163-72. PubMed ID: 25428574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study.
    Suomalainen A; Elo JM; Pietiläinen KH; Hakonen AH; Sevastianova K; Korpela M; Isohanni P; Marjavaara SK; Tyni T; Kiuru-Enari S; Pihko H; Darin N; Õunap K; Kluijtmans LA; Paetau A; Buzkova J; Bindoff LA; Annunen-Rasila J; Uusimaa J; Rissanen A; Yki-Järvinen H; Hirano M; Tulinius M; Smeitink J; Tyynismaa H
    Lancet Neurol; 2011 Sep; 10(9):806-18. PubMed ID: 21820356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity.
    Högel H; Rissanen E; Barro C; Matilainen M; Nylund M; Kuhle J; Airas L
    Mult Scler; 2020 Feb; 26(2):210-219. PubMed ID: 30570436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Score Based on NfL and Glial Markers May Differentiate Between Relapsing-Remitting and Progressive MS Course.
    Huss A; Otto M; Senel M; Ludolph AC; Abdelhak A; Tumani H
    Front Neurol; 2020; 11():608. PubMed ID: 32765393
    [No Abstract]   [Full Text] [Related]  

  • 11. Early death of ALS-linked CHCHD10-R15L transgenic mice with central nervous system, skeletal muscle, and cardiac pathology.
    Ryan ÉB; Yan J; Miller N; Dayanidhi S; Ma YC; Deng HX; Siddique T
    iScience; 2021 Feb; 24(2):102061. PubMed ID: 33659869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
    Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E
    Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum glial fibrillary acidic protein is a predictor of brain metastases in patients with metastatic breast cancer.
    Darlix A; Hirtz C; Mollevi C; Ginestet N; Tiers L; Jacot W; Lehmann S
    Int J Cancer; 2021 Oct; 149(8):1605-1618. PubMed ID: 34196964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Markers of Neurodegeneration Are Raised in Friedreich's Ataxia.
    Zeitlberger AM; Thomas-Black G; Garcia-Moreno H; Foiani M; Heslegrave AJ; Zetterberg H; Giunti P
    Front Cell Neurosci; 2018; 12():366. PubMed ID: 30425621
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of Blood Glial Fibrillary Acidic Protein as a Potential Marker in Huntington's Disease.
    You H; Wu T; Du G; Huang Y; Zeng Y; Lin L; Chen D; Wu C; Li X; Burgunder JM; Pei Z
    Front Neurol; 2021; 12():779890. PubMed ID: 34867769
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma neurofilament light chain and glial fibrillary acidic protein predict stroke in CADASIL.
    Chen CH; Cheng YW; Chen YF; Tang SC; Jeng JS
    J Neuroinflammation; 2020 Apr; 17(1):124. PubMed ID: 32321529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19.
    Aamodt AH; Høgestøl EA; Popperud TH; Holter JC; Dyrhol-Riise AM; Tonby K; Stiksrud B; Quist-Paulsen E; Berge T; Barratt-Due A; Aukrust P; Heggelund L; Blennow K; Zetterberg H; Harbo HF
    J Neurol; 2021 Oct; 268(10):3574-3583. PubMed ID: 33743046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders.
    Yatsuga S; Fujita Y; Ishii A; Fukumoto Y; Arahata H; Kakuma T; Kojima T; Ito M; Tanaka M; Saiki R; Koga Y
    Ann Neurol; 2015 Nov; 78(5):814-23. PubMed ID: 26463265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofilament Levels in CSF and Serum in an Adult SMA Cohort Treated with Nusinersen.
    Rich KA; Fox A; Yalvac M; Heintzman S; Tellez M; Bartlett A; Severyn S; Linsenmayer M; Kelly K; Reynolds J; Sterling GB; Weaver T; Rajneesh K; Pino MG; Arnold WD; Elsheikh B; Kolb SJ
    J Neuromuscul Dis; 2022; 9(1):111-119. PubMed ID: 34776417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrafamilial clinical variability in individuals carrying the CHCHD10 mutation Gly66Val.
    Pasanen P; Myllykangas L; Pöyhönen M; Kiuru-Enari S; Tienari PJ; Laaksovirta H; Toppila J; Ylikallio E; Tyynismaa H; Auranen M
    Acta Neurol Scand; 2016 May; 133(5):361-6. PubMed ID: 26224640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.